Evidence map›Paper›PMID 29574195›Full record

ReviewRegulatory toxicology and pharmacology : RTP2018

Characterizing risk assessments for the development of occupational exposure limits for engineered nanomaterials.

P A Schulte, E D Kuempel, N M Drew

Abstract readReview
In one paragraph

Review in Regulatory toxicology and pharmacology : RTP, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Risk Assessment of Nanomaterials Toxicity.Nanomaterials (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. lapdMouse: a data archive for advancing computational models of inhaled aerosol dosimetry.Journal of applied physiology (Bethesda, Md. : 1985) · 2020
    Article
  14. Article
  15. Article
  16. An Exploratory Assessment of Applying Risk Management Practices to Engineered Nanomaterials.International journal of environmental research and public health · 2019
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

P A SchulteNational Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, United States. Electronic address: PSchulte@cdc.gov.
E D KuempelNational Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, United States.
N M DrewNational Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, United States.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

The commercialization of engineered nanomaterials (ENMs) began in the early 2000's. Since then the number of commercial products and the number of workers potentially exposed to ENMs is growing, as is the need to evaluate and manage the potential health risks. Occupational exposure limits (OELs) have been developed for some of the first generation of ENMs. These OELs have been based on risk assessments that progressed from qualitative to quantitative as nanotoxicology data became available. In this paper, that progression is characterized. It traces OEL development through the qualitative approach of general groups of ENMs based primarily on read-across with other materials to quantitative risk assessments for nanoscale particles including titanium dioxide, carbon nanotubes and nanofibers, silver nanoparticles, and cellulose nanocrystals. These represent prototypic approaches to risk assessment and OEL development for ENMs. Such substance-by-substance efforts are not practical given the insufficient data for many ENMs that are currently being used or potentially entering commerce. Consequently, categorical approaches are emerging to group and rank ENMs by hazard and potential health risk. The strengths and limitations of these approaches are described, and future derivations and research needs are discussed. Critical needs in moving forward with understanding the health effects of the numerous EMNs include more standardized and accessible quantitative data on the toxicity and physicochemical properties of ENMs.

Indexed as

AnimalsHumansMaximum Allowable ConcentrationNanostructuresOccupational ExposureRisk AssessmentBiomarkersLung diseaseNanomaterialsNanoparticlesOccupational exposure limitsParticle overloadQuantitative risk assessmentRespiratory effects

Identifiers

PMID29574195
PMCPMC6075708

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.